|
GYRE Gyre Therapeutics Inc 1124105 |
| Balance Sheet |
|
Current Assets
|
54,809,000 |
|
Assets
|
125,240,000 |
|
Current Liabilities
|
14,716,000 |
|
Liabilities
|
26,766,000 |
|
Equity
|
98,474,000 |
|
Shares Out
|
93,424,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-883,000 |
|
Investing Cash Flow
|
-17,880,000 |
| Market Analysis |
Market Cap
|
1,318,215,429 |
|
Price
|
10.25 |
|
BVPS
|
1.05 |
|
PB
|
9.68 |
|
EPS
|
-0.86 |
|
PS
|
12.93 |
|
FCF
|
-18,763,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GYRE documents filed with the SEC.
GYRE Filings
Clear
